CIK 0001764013 · Large accelerated filer
Immunovant, Inc.
Sign in to watch- Ticker
- IMVT
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Mar 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 832771572
- Phone
- 917-410-3120
- Business address
- 1000 PARK FORTY PLAZA, DURHAM, NC, 27713
- Former names
- Health Sciences Acquisitions Corp
- 8-K Event Executive or director change
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- SEC STAFF LETTER Other SEC Staff Letter Redacted Exhibit
- UPLOAD Other SEC-generated Letter
- S-1 Offering Registration Statement
- SC 13D Stake Beneficial Ownership Report
- 4 Insider Changes in Ownership
- 3 Insider Initial Statement of Ownership
- SC 13D Stake Beneficial Ownership Report
- 8-K Event Material agreement · Acquisition or sale completed · Results of operations · Unregistered share sale · Shareholder rights changed · Auditor change · Change in control · Executive or director change
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
Page 28 of 33 · 652 filings